Systematic review of the incidence and prevalence of genital warts
H Patel, M Wagner, P Singhal, S Kothari - BMC infectious diseases, 2013 - Springer
Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …
[HTML][HTML] Genital warts: a comprehensive review
VR Yanofsky, RV Patel… - The Journal of clinical and …, 2012 - ncbi.nlm.nih.gov
External genital warts, also known as condylomata acuminata, are extremely common, with
between 500,000 to one million new cases diagnosed each year in the United States alone …
between 500,000 to one million new cases diagnosed each year in the United States alone …
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …
against human papillomavirus infection in the United Kingdom. Design Economic …
Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts
G Gross, H Pfister - Medical microbiology and immunology, 2004 - Springer
Using PCR, the overall prevalence of human papillomavirus (HPV) DNA in penile carcinoma
is about 40–45%, which is similar to the detection rate of HPV-DNA in vulvar carcinoma …
is about 40–45%, which is similar to the detection rate of HPV-DNA in vulvar carcinoma …
Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of …
PV Chin‐Hong, GE Reid… - Clinical …, 2019 - Wiley Online Library
These guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice update the epidemiology and management of human papillomavirus …
Community of Practice update the epidemiology and management of human papillomavirus …
[HTML][HTML] Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008)
In September 2008, the human papillomavirus (HPV) immunisation programme was
introduced in the UK for schoolgirls aged between 12 and 18 years of age. The vaccine …
introduced in the UK for schoolgirls aged between 12 and 18 years of age. The vaccine …
Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
Many countries are considering vaccination against human papillomavirus (HPV). However,
the long-term impact of vaccination is difficult to predict due to uncertainty about the …
the long-term impact of vaccination is difficult to predict due to uncertainty about the …
[HTML][HTML] Clinical and pathological aspects of condyloma acuminatum–review of literature and case presentation
D Diţescu, AM Istrate-Ofiţeru, GC Roşu… - Romanian Journal of …, 2021 - ncbi.nlm.nih.gov
Condyloma acuminatum (CA) is a pathology caused by the human papillomavirus (HPV). It
is manifested by the appearance of warts in the vulvar, pubic, and anorectal regions, but can …
is manifested by the appearance of warts in the vulvar, pubic, and anorectal regions, but can …
Patients with LR-HPV infection have a distinct vaginal microbiota in comparison with healthy controls
Y Zhou, L Wang, F Pei, M Ji, F Zhang, Y Sun… - Frontiers in cellular …, 2019 - frontiersin.org
Condyloma acuminatum (CA) is a benign epithelium hyperplasia mainly caused by human
papillomavirus (HPV), which is now the second most common viral sexually transmitted …
papillomavirus (HPV), which is now the second most common viral sexually transmitted …
School nurses' experiences of delivering the UK HPV vaccination programme in its first year
Abstract Background In the United Kingdom (UK) in September 2008, school nurses began
delivering the HPV immunisation programme for girls aged 12 and 13 years old. This study …
delivering the HPV immunisation programme for girls aged 12 and 13 years old. This study …